| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 85.26B | 85.21B | 82.05B | 85.33B | 78.65B | 81.65B |
| Gross Profit | 18.07B | 18.39B | 18.04B | 18.76B | 17.40B | 18.68B |
| EBITDA | 2.88B | 3.31B | 3.99B | 3.88B | 3.29B | 3.54B |
| Net Income | 759.00M | 1.10B | 1.31B | 1.48B | 939.00M | 626.00M |
Balance Sheet | ||||||
| Total Assets | 103.15B | 102.23B | 103.29B | 102.16B | 98.30B | 98.51B |
| Cash, Cash Equivalents and Short-Term Investments | 16.54B | 14.74B | 18.68B | 21.78B | 22.22B | 22.39B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 27.66B | 25.94B | 28.11B | 29.26B | 25.53B | 25.43B |
| Stockholders Equity | 75.48B | 76.28B | 75.18B | 72.90B | 72.78B | 73.08B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.69B | -2.07B | 2.46B | 2.33B | 4.16B |
| Operating Cash Flow | 0.00 | -423.00M | -210.00M | 3.67B | 3.58B | 6.05B |
| Investing Cash Flow | 0.00 | -2.75B | -345.00M | -874.00M | -1.41B | -1.82B |
| Financing Cash Flow | 0.00 | -817.00M | -863.00M | -816.00M | -815.00M | -959.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥17.54B | 2.31 | ― | 2.30% | 9.86% | 119.10% | |
76 Outperform | ¥552.61B | 11.76 | 8.08% | 2.25% | 3.33% | 9.57% | |
75 Outperform | ¥37.76B | 3.81 | ― | 3.56% | 3.03% | 160.39% | |
72 Outperform | ¥190.39B | 8.20 | ― | 3.41% | 6.17% | 61.39% | |
67 Neutral | ¥69.86B | 31.55 | 1.51% | 2.27% | 1.82% | -32.79% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
56 Neutral | ¥30.12B | 3.93 | ― | 2.94% | 0.41% | -51.02% |
Corona Corporation reported consolidated net sales of ¥69.2 billion for the quarter ended December 2025, essentially flat year on year, but saw profitability weaken, with operating profit down 27.6% to ¥1.69 billion and profit attributable to owners of parent falling 19.7% to ¥1.51 billion. Despite the earnings decline, total assets rose to ¥107.2 billion and net assets increased to ¥77.5 billion, though the capital adequacy ratio slipped slightly to 72.3%, and the company is maintaining its dividend stance with an annual forecast of ¥28 per share, signaling continued commitment to shareholder returns even amid margin pressure.
The most recent analyst rating on (JP:5909) stock is a Hold with a Yen952.00 price target. To see the full list of analyst forecasts on Corona Corporation stock, see the JP:5909 Stock Forecast page.